Tag Archives: Schedule 5
DEA Reclassifies Cannabis-Derived Epilepsy Treatment from Schedule I to 5
By Moira Feeney DEA notes that status change is specific only to Epidiolex and does not [...]
27
Sep
Sep
By Moira Feeney DEA notes that status change is specific only to Epidiolex and does not [...]